Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission

Positive anti-Dsg 3 ELISA and, to a lesser degree, positive DIF are predictors of relapse in PV patients in clinical remission. Decision on discontinuing treatment should be based on the results of these tests as well as on clinical findings.